Davidson Kempner Capital Management LP

Position in AVLN — Avalyn Pharma Inc.

CIK 1595082 New York, NY

Position in AVLN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$757,160

New position

Shares Held

23,000

first reported quarter

Ownership

0.052%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#58

of 91 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Davidson Kempner Capital Management LP holds $7,588,160 across 5 Biotechnology names. AVLN ranks #3 (10.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HUMA	Humacyte, Inc.	5,000,000	$3,900,000
2	KPTI	Karyopharm Therapeutics Inc.	300,000	$2,931,000
3	AVLN	Avalyn Pharma Inc. This page	23,000	$757,160
4	MLEC	Moolec Science SA	250,000	$0
5	TVGN	Tevogen Inc.	250,000	$0

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$757,160	23,000	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.